AdvaMed names Resmed’s Mick Farrell as new chair 

WASHINGTON – AdvaMed has announced that Mick Farrell, chairman and CEO of Resmed, will be the next chair of the AdvaMed board of directors. Farrell, who will serve a two-year term beginning in January 2026, succeeds Peter J. Arduini, president and CEO of GE HealthCare. “The entire board and the global industry AdvaMed represents are excited to have Mick as our chair during a rapidly evolving pace of medtech innovation,” said Scott Whitaker, AdvaMed president and CEO. “Whether in international forums or in the halls of the U.S. Congress, Mick’s enthusiasm for the power of medtech to change lives is endless and contagious. His egalitarian approach is inspiring. As chairman and CEO of Resmed, he is relentlessly committed to helping people sleep better, breathe better, and live longer, healthier lives. We’ll continue to take inspiration from his vision of life-changing medtech for all.” Farrell has served on the AdvaMed board of directors since 2015. He currently chairs the International Board Committee and recently joined an AdvaMed CEO delegation to Japan focused on medtech and healthy aging. He also contributed to several board committees and working groups. “It’s a privilege to follow in the footsteps of leaders like Mike Minogue, Ashley McEvoy and Pete Arduini, who each brought powerful focus to our shared goal of putting patients first, driving innovation, and shaping a better future for health care,” Farrell said. “As chair, I’ll build on that foundation. I’m focused on accelerating patient-first innovation, advancing digital transformation, and expanding global access to medtech. That means supporting policies that enable care to be delivered everywhere, from hospitals to homes, and personalizing that care for every individual. Together, we can share what’s next in health care, and I’m excited to get to work.”